Since the start of the COVID-19 pandemic, Labcorp has worked tirelessly to provide the kind of cutting-edge diagnostics and drug development breakthroughs that improve health and improve lives. Labcorp’s very own clinical research unit (CRU) in Leeds, U.K., recently helped to accelerate clinical trials of one such breakthrough: Ridgeback Biotherapeutics’ …
